This editorial discusses strategies for making public reports on healthcare organization performance more effective in improving quality of care. It identifies three potential pathways for reports to lead to better care: 1) Informing individual healthcare choices, 2) Stimulating delivery system improvements through market forces, and 3) Protecting professional reputations. However, most reports have had minimal impact. The editorial argues reports need to better communicate the existence and meaning of quality problems, provide a framework for understanding quality, and address consumer concerns to engage consumers. It suggests strategies like highlighting best and worst performers could boost all three pathways to impact.
SERVICES MARKETING BEHAVIOURAL CONSEQUENCES AND PATIENTS’ SATISFACTION TOWARD...IAEME Publication
Relationship marketing is an old idea but a new focus now at the forefront of services marketing practice and academic research. The impetus of its development has come from the maturing of services marketing, with the emphasis on quality, increased recognition of potential benefits for the firm, the customer, and technological advances. Relationship marketing works to attract maintain and enhance client/customer relationship in healthcare provider. Despite the widespread concern in health care literature with patients’ satisfaction there has been neither explicit definition of that concept nor systematic consideration of its determinants and consequences. Patients are becoming increasingly involved in making health care choices as their burden of health costs continue to escalate.
In this edition....Summaries of innovation projects
Resident transfers from aged care facilities to emergency departments: Can they be avoided?
NSW Trauma App
Queensland’s Digital Hospital
Investigating the relationship between emotional intelligence and transformation leadership in Nurse Managers
Embedding Consumer Engagement in Organisational Governance — Moving Consumers on Committees from Tokenistic to Having an Impact
UK Report Alcohol’s Impact on Emergency Services
SERVICES MARKETING BEHAVIOURAL CONSEQUENCES AND PATIENTS’ SATISFACTION TOWARD...IAEME Publication
Relationship marketing is an old idea but a new focus now at the forefront of services marketing practice and academic research. The impetus of its development has come from the maturing of services marketing, with the emphasis on quality, increased recognition of potential benefits for the firm, the customer, and technological advances. Relationship marketing works to attract maintain and enhance client/customer relationship in healthcare provider. Despite the widespread concern in health care literature with patients’ satisfaction there has been neither explicit definition of that concept nor systematic consideration of its determinants and consequences. Patients are becoming increasingly involved in making health care choices as their burden of health costs continue to escalate.
In this edition....Summaries of innovation projects
Resident transfers from aged care facilities to emergency departments: Can they be avoided?
NSW Trauma App
Queensland’s Digital Hospital
Investigating the relationship between emotional intelligence and transformation leadership in Nurse Managers
Embedding Consumer Engagement in Organisational Governance — Moving Consumers on Committees from Tokenistic to Having an Impact
UK Report Alcohol’s Impact on Emergency Services
The Future of Personalizing Care Management & the Patient ExperienceRaphael Louis Vitón
Actionable segmentation model findings - by Raphael Louis Vitón & Dream team of industry experts, physicians and leaders from Blue Cross, GEHealthCare, RingLeaderVentures, Maddock Douglas, Dr.Daniel Friedland, etc working on improving health outcomes by Personalizing the Care Management business model for Better Outcomes & Better Economics (through patient empowerment)
Best Practices in Patient Advocacy Groups Collaboration and Relationship Mana...Best Practices
The current structure of medical education emphasizes pedagogy related to the physician-patient relationship, and thus advocacy opportunities at this level. Patient and professional Advocacy Groups are important to the process of educating the marketplace on new therapies. Strong relationships with advocacy groups are important for educating the public on socially-sensitive conditions and treatment options.
Best Practices, LLC's study identifies effective practices in patient advocacy group collaboration and relationship management. This study also examines ideal structures and skill sets for pharma groups that deal with advocacy groups and emerging trends and challenges in patient advocacy.
Download Full Report: http://bit.ly/2evZ0AE
An introduction to BridgeHealth\'s innovative Surgery Benefit Management program that delivers claims savings by avoiding unnecessary surgeries and focusing on quality outcomes.
The Powerful and Evolving Role ofPatient Advocacy Groups in Orphan Drug Deve...PremierResearch_
Want to chat? Set up time to speak here: http://info.premier-research.com/TalktoPremier
A major goal of patient advocacy groups is to address the unmet needs of patients with cancer or rare diseases by providing access to the most effective drugs. In recent years, patient advocacy groups have expanded their influence over the drug development continuum from discovery to approval to market entry. Many groups directly fund, help design, or recruit patients to participate in clinical trials.
This webinar reviews the history of patient advocacy groups in advancing clinical research and examines the evolution of their role in light of recent and pending legislative and regulatory changes in the United States and European Union. Included is a discussion of how patient advocacy groups and industry can join to respond most effectively to these anticipated changes. Presenters are Susan Stein, MPH, a member of the Board of Directors of worldwide patient advocate umbrella organization Global Genes, and Juliet Moritz, MPH, Executive Director of Strategic Drug Development for Rare Diseases at Premier Research.
Addressing the Oncoming Paradigm Shift in American HealthcareLawrence Leisure
As I write this blog, I find myself frustrated with by the never-ending hand-wringing about the health care affordability crisis and the unsustainability of the cur rent benefit models for both employers and their employees. The time for action is now. It is my fervent belief that the opportunity for a paradigm change does exist and that we are rapidly approaching the tipping point; that valuable analogs exist and can guide us, and that there are offerings and platforms in the marketplace that can be repositioned or refined to enable the needed re-anchoring of the benefit commitment to a more stable care delivery model.
The Strategy of Identifying Solid Investment Opportunities in HealthcareTamas Ban, PhD, MBA
Consumerism in the healthcare industry is an inescapable growing trend. Patients are increasingly taking an active role in their care experience and are ever more empowered to choose their own care alternatives.
The key to driving a more consumer-based healthcare experience is to devise a cost-effective method to capture and analyze such information.
Healthcare is transforming into value-based healthcare, requiring investors to adjust their investment risk measures.
At the crossroads of healthcare and innovation lies service platform technologies. Hardware and service technologies will finally meet in 2016 to enable patient-centered healthcare services.
New key performance indicators (KPls) are necessary to measure patient outcomes, and new service platform technologies will use these new KPls.
Successful investments in healthcare ventures must show a positive impact on healthcare. The impact can be measured by cost, outcome, and alignment of incentives across payers, providers, and patients.
The 100-year-old methods used to measure the effects of medicine do not allow for personalization. Service platforms will bridge this gap.
Continuity of care relies on increasing the number of touch points, which service platform technologies will expand. They will also lead to connecting patients, providers, and payers to increase efficiency of patient care.
This paper will highlight a Quick Healthcare Value Assessment Tool for the investor.
The Future of Personalizing Care Management & the Patient ExperienceRaphael Louis Vitón
Actionable segmentation model findings - by Raphael Louis Vitón & Dream team of industry experts, physicians and leaders from Blue Cross, GEHealthCare, RingLeaderVentures, Maddock Douglas, Dr.Daniel Friedland, etc working on improving health outcomes by Personalizing the Care Management business model for Better Outcomes & Better Economics (through patient empowerment)
Best Practices in Patient Advocacy Groups Collaboration and Relationship Mana...Best Practices
The current structure of medical education emphasizes pedagogy related to the physician-patient relationship, and thus advocacy opportunities at this level. Patient and professional Advocacy Groups are important to the process of educating the marketplace on new therapies. Strong relationships with advocacy groups are important for educating the public on socially-sensitive conditions and treatment options.
Best Practices, LLC's study identifies effective practices in patient advocacy group collaboration and relationship management. This study also examines ideal structures and skill sets for pharma groups that deal with advocacy groups and emerging trends and challenges in patient advocacy.
Download Full Report: http://bit.ly/2evZ0AE
An introduction to BridgeHealth\'s innovative Surgery Benefit Management program that delivers claims savings by avoiding unnecessary surgeries and focusing on quality outcomes.
The Powerful and Evolving Role ofPatient Advocacy Groups in Orphan Drug Deve...PremierResearch_
Want to chat? Set up time to speak here: http://info.premier-research.com/TalktoPremier
A major goal of patient advocacy groups is to address the unmet needs of patients with cancer or rare diseases by providing access to the most effective drugs. In recent years, patient advocacy groups have expanded their influence over the drug development continuum from discovery to approval to market entry. Many groups directly fund, help design, or recruit patients to participate in clinical trials.
This webinar reviews the history of patient advocacy groups in advancing clinical research and examines the evolution of their role in light of recent and pending legislative and regulatory changes in the United States and European Union. Included is a discussion of how patient advocacy groups and industry can join to respond most effectively to these anticipated changes. Presenters are Susan Stein, MPH, a member of the Board of Directors of worldwide patient advocate umbrella organization Global Genes, and Juliet Moritz, MPH, Executive Director of Strategic Drug Development for Rare Diseases at Premier Research.
Addressing the Oncoming Paradigm Shift in American HealthcareLawrence Leisure
As I write this blog, I find myself frustrated with by the never-ending hand-wringing about the health care affordability crisis and the unsustainability of the cur rent benefit models for both employers and their employees. The time for action is now. It is my fervent belief that the opportunity for a paradigm change does exist and that we are rapidly approaching the tipping point; that valuable analogs exist and can guide us, and that there are offerings and platforms in the marketplace that can be repositioned or refined to enable the needed re-anchoring of the benefit commitment to a more stable care delivery model.
The Strategy of Identifying Solid Investment Opportunities in HealthcareTamas Ban, PhD, MBA
Consumerism in the healthcare industry is an inescapable growing trend. Patients are increasingly taking an active role in their care experience and are ever more empowered to choose their own care alternatives.
The key to driving a more consumer-based healthcare experience is to devise a cost-effective method to capture and analyze such information.
Healthcare is transforming into value-based healthcare, requiring investors to adjust their investment risk measures.
At the crossroads of healthcare and innovation lies service platform technologies. Hardware and service technologies will finally meet in 2016 to enable patient-centered healthcare services.
New key performance indicators (KPls) are necessary to measure patient outcomes, and new service platform technologies will use these new KPls.
Successful investments in healthcare ventures must show a positive impact on healthcare. The impact can be measured by cost, outcome, and alignment of incentives across payers, providers, and patients.
The 100-year-old methods used to measure the effects of medicine do not allow for personalization. Service platforms will bridge this gap.
Continuity of care relies on increasing the number of touch points, which service platform technologies will expand. They will also lead to connecting patients, providers, and payers to increase efficiency of patient care.
This paper will highlight a Quick Healthcare Value Assessment Tool for the investor.
In a health care system where consumers are empowered to actively choose among health plans, providers, and treatment options, delivering a satisfying customer experience is key to differentiation. The first step towards winning in a consumer-centric marketplace: understand how this new informed and engaged consumer views the health care system and how they define quality and value.
For more, check out the full report on the quest for value in health care: https://www.deloitte.com/view/en_US/us/Insights/centers/center-for-health-solutions/b57d260a4ac35410VgnVCM3000003456f70aRCRD.htm
Five years in, and the Affordable Care Act continues to command conversation in the benefits landscape. Industry players are still scrambling to implement new provisions, keep healthcare costs down, create infrastructure to support new reporting requirements, and develop new payer, provider and care delivery models.
This has, in turn pushed the respective hands of health plans, who have had to change their strategies to fit both the consumerization of insurance and the standards set forth under the ACA.
With end-users in the forefront, health plans must take the strategy implemented 15 years ago with the rise of the internet, and push the marketing and communication initiatives into overdrive to gain and retain customers.
Health plans are shifting their mentality and communication, ant the best of the best are putting time, money, and energy into literacy and new business initiatives.
To simplify, a health plan needs to put the consumer at the center of every decision it makes.
However, in order to plan, communicate, and effectively market to consumers, your health plan must know the consumer, the technology, and the future.
If you’re looking to grow your health plan, we have just released a new guide to help your health plan leverage trends in the post-reform consumer marketplace.
In our latest whitepaper, we share the keys to success for health plans, including the following:
Consumer Trends: Top 5 Healthcare Executive Consumer Strategy Points, Today’s Healthcare Consumers: Six Types of Consumers You Need to Know, Millennial Consumers Special Report
Technology Trends: Big Data, Administration Technology, Payment Technology, mHealth and more.
Future Trends: Accountable Care Organizations, The Future of Telehealth, Continues Rise of Private Exchanges
All of this, and insights on how to make it work for your health plan.
Download this detailed guide, Health Plans: Your Guide to Leveraging Trends in the Post-Reform Consumer Marketplace, free from the Healthcare Trends Institute.
http://www.evolution1.com/health-plans-your-guide-to-leveraging-trends-in-the-post-reform-consumer-marketplace.html
Navigating the Future of Healthcare at the Intersection of HCPs, Patients, an...No Fixed Address Health
Learn about the shifting landscape within healthcare decision-making and how the traditional model has evolved into a more collaborative approach. Discover three drivers within the life science marketing landscape accelerating this shift and what this all means to Pharma Brand Marketers. What's at stake for a brand failing to address these shifts?
Advertising AssignmentPick a global product brand and co.docxstandfordabbot
Advertising Assignment
Pick a global product / brand and country of interest to you (Do not choose South
Korea). In a 2-page report (double space), compare and contrast how that offering is
advertised in the USA and the foreign market. Please provide your thoughts pro and
con and any questions you have about the differences in marketing practice, as well as
any suggestions / recommendations for potentially doing things better. Source material
for this assignment can be obtained from an internet search and published journal
articles. Please provide a bibliographic list of your references at the back of your paper.
MLA Format.
Please reply to
William Polanco- Rowland–
Please note minimum of 200 words. Please cite one scholarly source. In-text citation should be included.
The cost of healthcare and the associated dollar signs connected to it has kept a certain number of patients away from seeing a doctor when needed. The creation of Managed Care Organizations exists to deal with the exorbitant prices associated with seeing a healthcare provider and actually decreasing costs while increasing the level of care (Nikitas et al, 2020). The common thread is the network of providers that exists within each network that agrees to provide care for the policy holders for an agreed price. Among the Managed Care Organizations are three plans known as Health Maintenance Organization (HMO’s), Preferred Provider Organization(PPO’s), and Point-Of-Service Plan (POS). The structure of HMO’s exists as a network of hospitals, doctors and providers that usually only pay for care in the network visits. These have lower premiums the insured must use a provider within the network that is their Primary Care Physician (PCP). In addition, referrals must be obtained from the PCPs for visits to specialists within the network (healthy.kaiserpermanente.org, 2022) Membership is generally required in the form of employment or one who lives in the area of coverage. With an associated higher cost is the PPO’s. They will allow for visits to in or out of network providers as well as cost of fee coverage for visiting those out of network providers, generally covered by the increased monthly premiums and out of pocket costs (healthy.kaiserpermanente.org, 2022). The third plan being mentioned here is the Point-Of-Service Plan (POS). This is considered a hybrid of plans which allows for the insured to make decisions to see who they want as a provider without first obtaining prior approval. With regard to a plan that works best for the consumer, the HMO plan is one where the nurse within the system is most connected to the providers and the case files allowing for a seamless connection with provider to facility. The other two plans have steps between each provider and information can be lost in the shuffle. The position of nurses working within the healthcare system allows them an opportunity to help keep health costs down via means of self aud.
76 CHAPTER 4 Assessing Health and Health Behaviors Objecti.docxpriestmanmable
76
CHAPTER 4
Assessing Health and Health Behaviors
Objectives
this chapter will enable the reader to:
1. Describe the expected outcomes of a nursing health assessment.
2. Identify the components of a nursing health assessment conducted for an individual client.
3. Examine life span, language, and culturally appropriate nursing health assessment tools for children, adults, and older adults.
4. Compare the similarities and differences among the various approaches to assessing the family, mindful of cultural influences.
5. Evaluate the criteria for conducting a screening in the community.
6. Compare the similarities and differences among the various approaches to assessing
the community.
Athorough assessment of health and health behaviors is the foundation for tailoring a health promotion-prevention plan. Assessment provides the database for making clinical judgments about the client’s health strengths, health problems, nursing diagnoses, desired health or behavioral outcomes, as well as the interventions likely to be effective. This information also forms the nature of the client–nurse partnership such as the frequency of con- tact and the need for coordination with other health professionals. The portfolio of assessment measures depends on the characteristics of the client, including developmental stage and cul- tural orientation. The nurse assesses age, language, and cultural appropriateness of the various measures selected.
Cultural competence is the ability to communicate effectively with people of different cultures. Providing culturally competent care is the cornerstone of the nursing assessment. The nurse’s aware- ness of her own attitude toward cultural differences and her cultural worldview and characteristics
Chapter4 • AssessingHealthandHealthBehaviors 77
are critical to her understanding and knowledge of various cultures. Recognizing that diversity exists in all cultures based on educational level, socioeconomic status, religion, rural/urban residence, and individual and family characteristics will ensure a more successful encounter (The Office of Minority Health, 2013). An online cultural educational program, designed specifically for nurses and featur- ing videotaped case studies and interactive tools, is available.
The Enhanced National Standards for Culturally and Linguistically Appropriate Services, based on a definition of culture expanded to include geography, spirituality, language, race and ethnicity, and biology, provides a practical guide to culturally and linguistically sensitive care (The Office of Minority Health, 2013).
Technology is having a significant impact on health care. The Electronic Health Record (EHR) promotes involvement of the client in developing a dynamic, tailored database. The EHR offers great promise to improve health and increase the client’s satisfaction with his care. Data aggregation, cross-continuum coordination, and clinical care plan management are critical com- ponents of the.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
[288 met]
1. International Journal for Quality in Health Care 2001; Volume 13, Number 5: pp. 353–355
Editorial
Being strategic with public reports
Evaluations indicate that comparative reports of health care adoption. There is, however, some evidence to support the
organization performance have had only minimal impacts on efficacy of a ‘reputation protection’ approach [3].
consumer behavior [1,2]. While the ultimate goal of public Although many report card developers hope that their
reports is to improve the quality of care, it is important to efforts will operate through all three pathways, they do not
note that there are different possible pathways and supporting necessarily use reporting strategies that support all three.
strategies to achieve this end. For example, some report card
developers have as their priority informed individual decision
making. Their concern is helping individuals to make effective What strategies are likely to support all
use of performance data in choosing providers and provider three pathways?
organizations, so that they are more likely to receive high
quality care. Although there may also be the hope that reports Improving communications about quality
will generate delivery system improvements, it is not their
primary objective. Some employers disseminate reports to All three pathways rely on consumers to pay attention to
employees with the primary purpose of helping their em- quality data and understand their import. Regrettably, it is in
ployees secure better care. this most basic area of getting consumers’ attention that we
Other report card developers are concerned about stimu- have been least successful [4]. This failure may be due to
lating improvements in the delivery of care. This approach some key ‘disconnects’ in the way we have communicated
relies on changing market dynamics and encouraging wide- about quality.
spread use of comparative data for making health selections. Firstly, we have not given consumers a compelling reason
The assumption here is that if many consumers make de- to pay attention. The public needs to be told that there is a
quality problem. Consumers assume a high and consistent
cisions on the basis of performance, high performing provider
level of clinical quality across providers and provider or-
organizations will gain market share. The theory is that a
ganizations. They have not been told otherwise, and report
shift in market share will motivate improvement among
card disseminators have been reluctant to do so. Consumers
competing organizations and ultimately there will be im-
will pay attention if they understand that they are at risk and
provements in care in the broader delivery system. That is,
could be harmed by poor quality care. To assume that the
care would be improved for all consumers, not just those
public is not interested in quality when they have not been
using comparative data to make selections. In the USA,
given the full story is a serious mistake.
coalitions of large purchasers of health care tend to pursue Secondly, there is a major disconnect between what con-
this ‘collective choice’ strategy. For example, the goal of Leap sumers think quality is and what we are attempting to convey
Frog, a group of large Fortune 500 companies, is to utilize in quality reports. We need to communicate what quality of
their role as health care purchasers to initiate breakthrough care is and what it is not. Surveys show that consumers think
improvements in the safety and overall value and quality of that quality is: doctor qualifications, ability to choose their
health care to American consumers. own doctor, costs, benefits, access [4]. While the professional
There is also a third possible pathway for public reports community has several frameworks for understanding quality
to result in improved care, the ‘reputation protection’ pathway. (e.g. evidence-based, underuse, overuse, misuse, etc.), the
It does not rely on consumer selection, but assumes that public does not. Providing a framework will help consumers
providers are motivated to improve in order to protect or understand what they should be looking for and help them
enhance their professional/institutional reputations. When to understand the meaning of comparative performance data.
performance is made public, and the public pays attention, In focus groups with consumers, the concept of evidence-
institutional and provider reputations and public images could based care was explained [5]. Participants understood the
be affected. This benefit or threat may be sufficient to concept and thought it was a highly valuable way to un-
motivate improvements. derstand what good care should be. Furthermore, once
It is not clear which, if any, of these pathways will eventually participants understood the concept, comparative data on
be effective in stimulating improved care. Most attention has evidence-based care were much more meaningful to them.
been on the collective and individual choice pathways, even Communicating a framework that helps consumers un-
though there is minimal evidence that these approaches are derstand quality does not have to be complex or elaborate.
influencing consumers [1,2]. It may be that it will take For example, indicating that health care should be safe,
more time for consumers to adopt the innovation of using effective, and responsive to patient’s needs is easily un-
comparative reports. Furthermore, it is possible that poorly derstandable and communicates what is meant by quality.
designed and difficult to use reports have slowed their Thirdly, if we want consumers to pay attention, then
2001 International Society for Quality in Health Care and Oxford University Press 353
2. Editorial: J. Hibbard
comparative reports need to address consumer concerns. If, for example, people form a generalized impression
Consumers do have real concerns about health care. They about the quality and/or safety of a hospital, based on an
have worries that their health plan will put financial concerns evaluable comparative report, this can be a powerful threat
above considerations of good care, and that should they or benefit to that hospital. A generalized impression would
become seriously ill, their health plan will not deliver the likely be communicated to family and friends over time (just
needed care [6]. Yet most comparative reports do not directly as impressions of restaurants and schools are communicated),
address these concerns. When comparative reports do carry creating a wider net of those holding this impression. Fur-
messages that speak directly to these types of concerns, they thermore, we know that when people must make choices of
are attended to by consumers to a greater degree, are better hospitals or plans they ask a friend or family member. Thus,
understood, and the information more highly valued than an evaluable report might eventually indirectly influence
reports that fail to address these concerns [7]. consumer choice as well.
Finally, while most comparative reports focus on health Thus, using evaluable reporting approaches, or ones that
plans, consumers are most interested in provider level data highlight for the viewer better and worse performers, could
[8]. There is broad recognition of this need, and while boost the impact of all three pathways.
there are measurement challenges, comparative reports are On the other hand, if we wanted to boost just the ‘choice
beginning to move in this direction with physician group pathways’, providing comparative information along with
performance reports. decision-support tools would help consumers use the data in
To summarize, if consumers understood the scope and decision making. Decision-support tools can help consumers
the nature of the quality problem and the risks they face individually weight and bring together all the relevant factors
from poor quality care, if they understood what was meant (costs, benefits, quality) into a choice. Use of these tools
by quality of care, and if reports spoke directly to consumer could enhance the likelihood that quality data would be
concerns and interests, then it is highly likely we would see included in choice. The tools would likely not affect in-
more consumer attention to quality reports. Of course wide stitutional reputation, however, and would not motivate pro-
dissemination and promotion of the reports are also needed viders to improve as a way of protecting their image. Thus,
to boost exposure to the information. designing effective public reports needs to begin with a clear
understanding of which pathways are being pursued.
In summary, evaluations are needed that illuminate which
Making quality reports easier to use
pathways are most effective in achieving improvements in
Once we have consumers’ attention there is still the problem care. Furthermore, we are just beginning to understand how
that the reports are complex and burdensome to use. They the reputation protection pathway works and what factors
have too much data and conflicting information (e.g. a health boost the impact of that pathway. Although we have labora-
plan that is good on one measure and poor on another), tory research indicating which reporting strategies are likely
leaving the viewer confused and unsure of what to do with to increase the use of comparative performance data in
the information. choice, we need to see how well these findings hold up in
Is there a way to make it easier to use the reports? Our real life decisions. Until there is more empirical evidence
findings from recent laboratory studies begin to answer this about which pathways are more effective in stimulating quality
question. Our experiments were designed to determine how improvement, using reporting strategies that have been tested
presentation approach, including presentation approaches in the laboratory and are likely to boost the impact of all
designed to be ‘evaluable’, affects the interpretation and use three pathways may be the safest approach.
of data [9]. ‘Evaluability’ refers to presenting information in
a way that makes it easier to discern better and worse Judith H. Hibbard
options. The findings show that using evaluable presentation University of Oregon
approaches (e.g. ordering by performance or using visual Eugene, OR, USA
cues that help identify high performers) resulted in making
the information easier to interpret and more likely to actually
be used in choice. Thus, the findings suggest that using References
‘evaluable’ presentation approaches would enhance the
‘choice’ pathways. Moreover, because they highlight better 1. Mukamel DB, Mushlin AI. The impact of quality report cards
and worse options, they would likely boost the effect of the on choice of physicians, hospitals, and HMOs: a midcourse
‘reputation’ pathway as well. evaluation. Jt Comm J Qual Improv 2001; 27: 20–27.
Institutions spend substantial resources and effort in build-
ing a public image of trust, safety, and quality. Through a 2. Marshall MN, Shekelle PG, Leatherman S, Brook RH. The
coordinated communication and advertising strategy, referred public release of performance data: what do we expect to gain?
A review of the evidence. J Am Med Assoc 2000; 283: 1866–1874.
to as ‘branding’, institutions try to create a generalized positive
impression. A public report that is easy to digest and one 3. Fowles JB. Health Plan Report Cards May Influence Insurers More
where it is easy to discern high and poor performers (using Than Consumers: Their Effect on Insurer Behavior in Minnesota.
evaluable presentation formats) could threaten or support an Findings Brief. Washington, DC: Health Care Financing &
institution’s public image. Organization, Alpha Center, 2000.
354
3. Editorial: J. Hibbard
4. Kaiser Family Foundation. National Survey on Americans as Health 7. Hibbard JH, Harris-Kojetin L, Mullin P, Lubalin J, Garfinkel S.
Care Consumers: An Update on the Role of Quality Information. Menlo Increasing the impact of health plan report cards by addressing
Park, CA: Kaiser Family Foundation, 2000. consumers’ concerns. Health Aff (Millwood) 2000; 19: 138–143.
8. Hibbard JH, Jewett JJ. What type of quality information do
5. VHA. Consumer Demand for Clinical Quality: The Giant Awakens.
consumers want in a health care report card? Med Care Res Rev
VHA’s 2000 Research Series, Volume 3. Irving, TX: VHA Inc.,
1996; 53: 28–47.
2000.
9. Hibbard JH, Slovic P, Peters E, Finucane ML. Strategies for
6. Blendon RJ, Brodie M, Benson JM et al. Understanding the reporting health plan performance information to consumers:
managed care backlash. Health Aff (Millwood) 1998; 17: 80–94. evidence from controlled studies. Health Serv Res 2001; in press.
355